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Received January 11, 2012; accepted April 2, 2012AbstractBackground: Hyponatremia is related to cardiac tamponade in isolated case reports. However, the incidence of hyponatremia in patients with
cardiac tamponade is still undetermined.
Methods: In a tertiary referral medical center, patients who presented with cardiac tamponade necessitating evacuation of pericardial effusion
were included. Medical records were reviewed for the diagnosis of effusion and the underlying disease in each patient. Serum sodium
concentrations before and after evacuation of effusion were analyzed.
Results: A total of 48 patients were identified during a 3-year period and 26 patients (54.2%) were found to have hyponatremia. The condition
was mild (130e134 mEq/L) in eight; moderate (120e129 mEq/L) in 16; and severe (<120 mEq/L) in two patients. The frequency of hypo-
natremia was significantly higher in patients with malignancy-related rather than nonmalignancy-related cardiac tamponade (62.2% vs. 27.3%,
p ¼ 0.041). Nineteen patients had hyponatremia at presentation and had paired serum sodium concentrations measured after evacuation of
pericardial effusion. The postevacuation serum sodium concentrations were significantly higher than the pre-evacuation levels in all patients
( p < 0.001).
Conclusion: Hyponatremia is common in patients with cardiac tamponade. However, prompt management of pericardial effusion will result in
spontaneous and rapid recovery from hyponatremia.
Copyright  2012 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Hyponatremia (serum sodium concentration <135 mEq/L)
is one of the most commonly encountered electrolyte abnor-
malities in daily practice. Its clinical manifestations may range
from asymptomatic, lethargy, convulsion, and coma, depend-
ing on the severity and rapidity of the occurrence of hypona-
tremia. Hyponatremia itself is not a disease but a manifestation
of variable kinds of diseases.1,2 Most of the underlying causes
of hyponatremia are associated with low plasma osmolarity,
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diagnosis.3
Hyponatremia is frequently observed in cancer patients,
with an incidence ranging from 3.7% to 47%.4,5 The etiology
include, but are not restricted to: (1) tumor-secreting factors
such as antidiuretic hormone (ADH) and atrial natriuretic
peptide (ANP), (2) tumor-related anorexia and emotional
stress, and (3) treatment-induced side effects such as vomiting,
diarrhea, and renal toxicity. Although the severity of hypo-
natremia is usually mild to moderate and its development is
protracted in most cancer patients, an accurate diagnosis is
important because inappropriate management may lead to
further reduction of the serum sodium concentration and
adverse clinical outcome.
Recently, we observed a lung cancer patient who presented
to the emergency department with cardiac tamponade. He alsohinese Medical Association. All rights reserved.
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deficit. A percutaneous indwelling catheter was inserted in
order to evacuate the massive pericardial effusion for both
diagnosis and symptom relief. Interestingly, the patient’s
severe hyponatremia recovered spontaneously and rapidly
without any other treatment. We reviewed the literature and
found only four isolated case reports.6e9 Because cardiac
tamponade was not previously considered a cause of hypo-
natremia,1e3 it is not clear whether these observations were
simply coincidental or important hints that were heretofore
ignored. In this retrospective study, to determine the rela-
tionship between hyponatremia and cardiac tamponade, we
systemically analyzed the frequency of hyponatremia and the
effect of pericardial drainage on serum sodium concentrations
in patients with cardiac tamponade.
2. Methods2.1. PatientsTable 1Because a cytology test is part of the standard group of
examinations for undetermined pericardial effusion, we used
our cytology database to retrieve cases that had significant
and/or undiagnosed pericardial effusion between January 2007
and December 2009. We then performed an electronic chart
review to find patients who had cardiac tamponade that war-
ranted percutaneous indwelling catheter drainage or pericar-
dial window surgery for symptom relief. Patients who had
serum sodium concentrations checked within 48 h before the
evacuation of pericardial effusion were considered eligible for
analysis. Those who had paired serum sodium concentrations
measured after evacuation (<48 h) and did not receive any
specific medication to correct hyponatremia were enrolled for
further analysis of the effect of pericardial drainage on
hyponatremia. This study was carried out in a tertiary referral
medical center and conducted in accordance with the Decla-
ration of Helsinki.Patient characteristics.
n %2.2. Statistical analysis
Sex
Men 29 (60.4)
Women 19 (39.6)
Age (yrs)
Median (range) 61 (23e81)
Diagnosis
Malignant 37 (77.1)
Non-small cell lung cancer 28 (58.3)
Small cell lung cancer 5 (10.4)
Breast cancer 1 (2.1)
Esophageal cancer 1 (2.1)
Thymoma 1 (2.1)
Angiosarcoma 1 (2.1)
Benign 6 (12.5)
Tuberculosis 1 (2.1)
Systemic lupus erythematosus 1 (2.1)
Hypothyroidism 1 (2.1)
Uremia 1 (2.1)
Iatrogenic 1 (2.1)
Idiopathic 1 (2.1)
Undetermined 5 (10.4)Patients with pretreatment serum sodium concentrations
were included and Pearson’s chi-square test was used to
analyze the differential frequency of hyponatremia in patients
with malignancy-related versus. nonmalignancy-related
cardiac tamponade. Wilcoxon signed-rank test was used to
analyze paired serum sodium concentrations before and after
pericardial effusion drainage. A p value less than 0.05 was
considered statistically significant. SPSS Statistics 17.0 (SPSS
Inc., Chicago, IL, USA) was used to carry out the analysis and
Microsoft Excel 2007 (Microsoft Corp., Redmond, WA, USA)
was employed to construct the figures.
3. Results
Fifty-seven patients were identified in a 3-year period and
nine patients were excluded due to lack of serum sodium level
measurement within 48 h before pericardial drainage. Asa result, 48 patients were enrolled and patient characteristics
are summarized in Table 1. Most of the patients were male
(60%) and the median age was 61 years (range ¼ 23e81).
Thirty-seven patients had active malignancy at the time of
presentation of cardiac tamponade, and 33 of them were lung
cancers. Six patients had benign pericardial effusion, caused
by tuberculosis, systemic lupus erythematosus, hypothy-
roidism, uremia, iatrogenic (caused by percutaneous trans-
luminal coronary angioplasty), and idiopathic (survived
without recurrence of effusion and was free from any malig-
nancy for more than 2 years), respectively. A definite diag-
nosis of pericardial effusion could not be established in five
patients. Four of them died soon thereafter, in spite of the
effective management of cardiac tamponade, and one was
discharged without specific diagnosis and lost to follow-up.
The cytology and microbiology examinations were all nega-
tive in these five patients.
In this series, 26 patients (54.2%) had hyponatremia. The
condition was mild (130e134 mEq/L) in eight; moderate
(120e129 mEq/L) in 16; and severe (<120 mEq/L) in two
(Table 2). Among the 37 patients exhibiting malignancy-
related cardiac tamponade, 23 (62.2%) had hyponatremia
and the condition was mild in 6 and moderate to severe in 17.
Among those with benign or undetermined pericardial
effusion, only three (27.3%) had hyponatremia, with the
condition being mild in two and moderate in the other. The
presence of hyponatremia was not associated with age or sex;
however, it was significantly associated with the underlying
disease (malignancy vs. non-malignancy, 62.2% vs. 27.3%,
p ¼ 0.041). In patients who had hyponatremia at presentation,
19 had paired serum sodium levels measured within 48 h
after evacuation of pericardial effusion. None of them had
received specific treatment to correct hyponatremia. The
postevacuation serum sodium levels were significantly higher
than the pre-evacuation levels ( p < 0.001). In fact, all patients
Table 2
Summary of the severity of hyponatremia and the nature of pericardial
effusion.
Serum Na level (mEq/L) Nature of pericardial effusion
Benign Undetermined Malignant
135 5 3 14
130e134 1 1 6
120e129 0 1 15
<120 0 0 2
511F.-K. Chang et al. / Journal of the Chinese Medical Association 75 (2012) 509e512had higher post-treatment serum levels with a median increase
of 8 mEq/L (range, 1e14 mEq/L). This is shown in Fig. 1.
Twelve patients (63.2%) showed an increase by at least 5%
and seven of them showed an absolute increase of 10 mEq/L
or more. Despite the dramatic changes in serum sodium
concentrations, none of the patients developed major neuro-
logic deficit during or after evacuation of pericardial effusion.
4. Discussion
Hyponatremia is a common clinical manifestation of
several kinds of diseases. The list of differential diagnosis is
lengthy;1e3 however, cardiac tamponade is not a part of this
list. We reviewed the literature and found only four isolated
case reports.6e9 To the best of our knowledge, this study is the
first to systemically investigate serum sodium concentrations
in patients with cardiac tamponade. We showed that hypona-
tremia was indeed frequently encountered in patients with
cardiac tamponade, at least in those who had active malig-
nancy. In addition, by comparing the serum sodiumFig. 1. Serum sodium levels before and after evacuation of pericardial effusion
(n ¼ 19). The median level was 127 mEq/L and 135 mEq/L, respectively.concentration before and after pericardiocentesis, we provided
strong evidence suggesting a causative role of cardiac tam-
ponade in the development of hyponatremia. However, it is
noteworthy that only one-half of the patients’ serum sodium
levels returned to normal range after pericardial drainage.
Therefore, we considered cardiac tamponade to be a critical
but not the sole contributing factor to hyponatremia in these
patients.
The mechanism as to how cardiac tamponade causes
hyponatremia is not clear. Previous animal study had shown
that circulating ADH, which is stimulated by increased atrial
pressure,10 was elevated in dogs with experimental cardiac
tamponade.11 Indeed, elevated serum ADH levels were
observed in clinical patients.6,12 Then it was suggested that
the “inappropriate” secretion of ADH was the principle factor
for the development of hyponatremia. However, this proposal
was contradicted by the clinical finding that patients’ serum
sodium levels were paradoxically decreased when they were
treated by water restriction.7 Atrial natriuretic factor (ANF)
had also been implied to be responsible for hyponatremia in
cardiac tamponade. However, it is now clear that atrial
distension, but not atrial pressure elevation, causes ANF
release from atrial myocardiocyte. In cardiac tamponade,
although atrial pressure is elevated, transmural pressure is
maintained and then ANF is not secreted.11,13 Reduced
effective volume, and then decreased glomerulus filtration rate
in the presence of cardiac tamponade may play a key role in
the development of hyponatremia. In fact, simple fluid
hydration is adequate to correct hyponatremia. However, the
reasons why hyponatremia occurs in some patients with
cardiac tamponade but not others are still unknown.
In this study, almost all patients experienced spontaneous
and rapid recovery of hyponatremia after evacuation of peri-
cardial effusion. We consider this result multifactorial. The
relief of cardiac tamponade may (1) reduce atrial pressure and
then inhibit further ADH secretion, (2) increase the atrial
transmural pressure resulting in atrial distension and ANF
release, and (3) improve the effective circulating volume and
then increase glomerulus filtration rate. All of these effects
will result in diuresis, which is commonly seen in clinical
patients undergoing pericardiocentesis, and correction of
hyponatremia. In fact, the consequence of pericardial drainage
on serum sodium levels has even been demonstrated in an
animal model of pericardial effusion.14
Interestingly, our study showed a significantly higher inci-
dence of hyponatremia in patients with malignancy-related
than those with nonmalignancy-related cardiac tamponade.
In addition, most patients with malignancy-related cardiac
tamponade had moderate to severe hyponatremia, but for those
without active malignancy history, only one had a serum
sodium level less than 130 mEq/L. Although the mechanism is
yet to be determined, it is plausible that cancer cells may not
only result in large amount of pericardial effusion but also
induce significant pericardial fibrosis, which may have an
influence on atrial transmural pressure and ANF secretion. A
detailed hemodynamic-pathological correlation study is
needed to clarify this issue.
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implications. First, cardiac tamponade should be in the differ-
ential diagnosis of hyponatremia, especially in patients with
activemalignant disease. Secondly, it is better to defer treatment
until a diagnosis is made. Inappropriate secretion of ADH is the
leading cause of hyponatremia in cancer patients,15 and water
restriction is the treatment of choice. However, in patients with
cardiac tamponade-related hyponatremia, water restriction may
actually worsen the hyponatremia. In fact, it could have
a detrimental effect on hemodynamic status in these patients.
Thirdly, the presence of moderate to severe hyponatremia in
patients with cardiac tamponade may serve as a clue for the
diagnosis of pericardial effusion, since it was relatively rare in
benign pericardial disease in our series.
This study had some limitations. It was a retrospective
clinical observation; therefore, the patient population might
include some bias. The diagnosis of cardiac tamponade and
the decision to undergo pericardiocentesis were made by an
individual in-charge physician. We considered that both the
echocardiographic findings and the hemodynamic changes in
patients with cardiac tamponade were important in the severity
evaluation of tamponade, which, in turn, would help to
elucidate the underlying pathogenesis of hyponatremia in
these patients. However, these data were not informative in
a retrospective study. We believe a prospectively designed
clinical trial in which echocardiography and hemodynamic
evaluation are performed in a predefined methodology is
warranted. In addition, we retrieved patients from the cytology
database; therefore, we might fail to enroll patients who
already been diagnosed before pericardiocentesis, where the
resulting pericardial effusion was not sent for cytology
examination. This may partially explain the unusual ratio of
malignancy-related to non-malignancy-related cardiac tam-
ponade in our cohort.
In conclusion, cardiac tamponade should be considered
in the differential diagnosis of hyponatremia, especially in
patients with active malignant disease. It is of significant
clinical importance because prompt management of cardiac
tamponade per se can be sufficient to result in rapid recovery
of hyponatremia.Acknowledgments
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